MCKESSON CORP MCK 69.26
Health Care · NYSE · Data as of 2026-08-05
MCKESSON CORP (MCK) has delivered +8.0% annualized revenue growth, n/a earnings growth, and +3.7% dividend growth over 10 years of data. Ranked #287 of 1968 stocks overall and #31 of 260 in the Health Care sector by Steady Score.
About MCKESSON CORP
Company Overview
McKesson distributes pharmaceuticals and medical products and provides technology and services across healthcare. It supplies retail pharmacies, hospitals, clinics and health systems with brand-name, generic and specialty medicines. The company also supports oncology practices, biopharmaceutical manufacturers and pharmacies with sourcing, logistics, patient access and software. Operations are concentrated in North America with selected international activities.
Read more
Business Model & Revenue
Revenue comes mainly from purchasing drugs and reselling them at large volume and narrow margins. U.S. Pharmaceutical distributes medicines; Prescription Technology Solutions connects patients, providers, pharmacies and manufacturers; Medical-Surgical supplies care sites; International covers remaining markets. Prescription volume, drug pricing, generic sourcing, customer contracts and specialty services determine gross profit more than headline revenue.
Key Facts & Market Position
McKesson is a critical intermediary in a highly regulated supply chain, requiring secure warehouses, controlled-substance compliance and reliable delivery. Scale supports purchasing and nationwide distribution, while large customers and suppliers create concentration. Specialty drugs, oncology networks and access services broaden economics beyond conventional wholesale and connect the company more closely with manufacturers.